Core Scientific Inc (CORZ)

Over the past six months, Core Scientific's stock has gained 31.79%. The company's strategic pivot to AI infrastructure is largely attributed to its strategic execution of a full pivot from Bitcoin mining to AI-focused HPC hosting. Keefe, Bruyette & Woods raised its price target for CORZ to $25 from $19, issuing an "Outperform" rating, citing the company's strategic transition. BTIG upgraded CORZ to "Buy" in January 2026, acknowledging the "dust settled" after a rejected merger and positioning the firm for growth in 2026. Citizens also upgraded Core Scientific's stock rating to Market Outperform in December 2025. In October 2025, Core Scientific stockholders did not approve a previously announced merger agreement with CoreWeave, Inc., leading the company to refocus on its standalone growth prospects in high-density colocation. In October 2025, Core Scientific announced its fiscal third-quarter 2025 results, reporting total revenue of $81.1 million, a net loss of $146.7 million, and an increase in high-density colocation revenue to $15.0 million. In August 2025, the company reported total revenue of $78.6 million and a net loss of $936.8 million. Core Scientific has significant HPC hosting contracts with CoreWeave, including agreements for 270 MW of infrastructure representing over $4.7 billion in potential revenue over 12-year terms.

Demand seasonality for Core Scientific's products and services is evolving with its strategic pivot. Historically, digital asset mining revenue could be influenced by factors such as Bitcoin price volatility and halving events. The demand for high-density colocation services, particularly for AI and HPC workloads, is described as robust and expanding, driven by the continuous growth of AI and enterprise workloads. Core Scientific's shift aims to replace volatile mining income with more stable, data-center-like revenue streams.

Core Scientific operates in the Technology sector, focusing on software and digital infrastructure for high-performance computing. The company designs, builds, and operates digital infrastructure, offering services segmented into Digital Asset Self-Mining, Digital Asset Hosted Mining, and HPC Hosting. It is transitioning from Bitcoin mining to providing HPC infrastructure for AI and machine learning, aiming to capitalize on the demand for compute power driven by the AI boom. Major products and services include high-density colocation solutions for AI, cloud services, healthcare, hyperscalers, manufacturing, and professional services, offering scalable infrastructure with high power densities and advanced direct liquid-cooling.

Core Scientific operates dedicated colocation facilities across seven U.S. states, including one facility in Alabama, two in Georgia, one in Kentucky, one in North Carolina, one in North Dakota, one in Oklahoma, and three in Texas. The company has over 1,300 MW of contracted power capacity across its U.S. locations.

Core Scientific's brand reputation has been shaped positively by its strategic shift from Bitcoin mining to high-density colocation for AI and HPC. The company is seen as being at the forefront of a major shift in digital infrastructure for high-performance computing, particularly GPU-based workloads essential for AI. Recent upgrades from analyst firms like Keefe, Bruyette & Woods and BTIG, along with a "Moderate Buy" consensus rating from 21 Wall Street analysts, reflect a positive perception of the company's direction and potential. The foundational partnership with CoreWeave for AI hosting capacity has been a significant positive for Core Scientific's reputation. The shareholder rejection of the CoreWeave merger in October 2025 could have been a reputational challenge; however, the company's subsequent reaffirmation of its commitment to repurposing facilities for high-density colocation and its focus on standalone growth has helped to reframe this event as a strategic reset.

Core Scientific has a diverse ownership structure comprising institutional, insider, and public investors. As of February 5, 2026, Core Scientific has 563 institutional owners holding a total of 352,697,983 shares, representing approximately 31.48% of the company's stock. Individual investors, along with public companies, own approximately 65.43% of the company's stock. Key insider shareholders, as of February 6, 2026, include CEO Adam Taylor Sullivan (4.13 million shares), Director Darin Feinstein (4.00 million shares), and Director Matt Minnis (3.25 million shares).